Fresno Institute of Neuroscience, Fresno, CA 93720, USA.
Medicina (Kaunas). 2022 Sep 28;58(10):1368. doi: 10.3390/medicina58101368.
Although dementia is a common and devastating disease that has been studied intensely for more than 100 years, no effective disease modifying treatment has been found. At this impasse, new approaches are important. The purpose of this paper is to provide, in the context of current research, one clinician's perspective regarding important challenges in the field in the form of specific challenges. These challenges not only illustrate the scope of the problems inherent in finding treatments for dementia, but can also be specific targets to foster discussion, criticism and new research. One common theme is the need to transform research activities from small projects in individual laboratories/clinics to larger multinational projects, in which each clinician and researcher works as an integral part. This transformation will require collaboration between researchers, large corporations, regulatory/governmental authorities and the general population, as well as significant financial investments. However, the costs of transforming the approach are small in comparison with the cost of dementia.
尽管痴呆症是一种常见且具有破坏性的疾病,已经被研究了 100 多年,但仍未找到有效的治疗方法。在这种僵局下,新的方法非常重要。本文旨在结合当前的研究,以具体挑战的形式,为该领域的重要挑战提供一个临床医生的视角。这些挑战不仅说明了寻找痴呆症治疗方法所固有的问题的范围,而且还可以作为促进讨论、批评和新研究的具体目标。一个共同的主题是需要将研究活动从个别实验室/诊所的小型项目转变为更大的跨国项目,每个临床医生和研究人员都作为一个整体参与其中。这种转变将需要研究人员、大公司、监管/政府机构和公众之间的合作,以及大量的财务投资。然而,与痴呆症的成本相比,转变方法的成本很小。